Cite
HARVARD Citation
Yang, H. et al. (2018). Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer. Scientific reports. 8 (1), pp. 1-2. [Online].